-
1
Nephrotoxicity of HAART
Published 2011-01-01“…Highly active antiretroviral therapy (HAART) and other medical therapies for HIV-related infections have been associated with toxicities. …”
Get full text
Article -
2
-
3
Treatment of CMV Retinitis with Intravitreal Ganciclovir in the HAART Era
Published 2001-01-01“…OBJECTIVE: To describe the course and outcome of cytomegalovirus (CMV) retinitis among AIDS patients treated with intravitreal ganciclovir and systemic highly active antiretroviral therapy (HAART). The secondary objective was to compare the course of CMV retinitis between patients receiving HAART and those not receiving this treatment.…”
Get full text
Article -
4
Kaposi Sarcoma of the Eye in an HIV Patient Well-responded to HAART
Published 2016-05-01“…Nowdays, incidence of Kaposi sarcoma has decreased in developed countries in the era of Highly Active Antiretroviral Therapy (HAART) but still a big problem in resource-limited areas such as Sub- Saharan Africa. …”
Get full text
Article -
5
Intensive Care Usage by HIV-Positive Patients in the HAART Era
Published 2011-01-01Get full text
Article -
6
The Impact of HIV on Maternal Morbidity in the Pre-HAART Era in Uganda
Published 2012-01-01Get full text
Article -
7
Kaposi Sarcoma of the Eye in an HIV Patient Well-responded to HAART
Published 2016-05-01“…Nowdays, incidence of Kaposi sarcoma has decreased in developed countries in the era of Highly Active Antiretroviral Therapy (HAART) but still a big problem in resource-limited areas such as Sub- Saharan Africa. …”
Get full text
Article -
8
A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Published 2016-01-01“…<h4>Objectives</h4>Primarily to quantify and compare the risk of having diabetes mellitus in HIV/AIDS patients on HAART and HAART-naïve patients in Limbe, Cameroon; and secondarily to determine if there is an association between HAART and increased DM risk.…”
Get full text
Article -
9
Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS Patient
Published 2014-10-01“… HIV infection has been considered as a chronic illness since the availability of highly active anti retroviral treatments (HAART). The introduction of HAART to HIV/AIDS patient improve quality of life, life expectancy, decrease rate of resistance and further decrease mortality to AIDS related causes. …”
Get full text
Article -
10
Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy
Published 2012-01-01“…Sensory neuropathy (SN) is one of the most common AIDS-associated neurologic disorders especially in the era of highly active antiretroviral therapy (HAART). The aim of this study was to determine the prevalence of SN among highly-active-antiretroviral-therapy- (HAART-) experienced and HAART-naïve HIV-positive individuals and to investigate the relationship to demographic, clinical, and laboratory factors. …”
Get full text
Article -
11
Parkinsonism and AIDS: a clinical comparative study before and after HAART
Published 2009-09-01“…We conclude that after the introduction of HAART there was an evident decrease in AIDS-related Parkinsonism.…”
Get full text
Article -
12
Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS Patient
Published 2014-10-01“… HIV infection has been considered as a chronic illness since the availability of highly active anti retroviral treatments (HAART). The introduction of HAART to HIV/AIDS patient improve quality of life, life expectancy, decrease rate of resistance and further decrease mortality to AIDS related causes. …”
Get full text
Article -
13
Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.
Published 2009-07-01“…<h4>Background</h4>Prevalence and risk factors for respiratory symptoms and airway obstruction in HIV-infected subjects in the era of highly active antiretroviral therapy (HAART) are unknown. We evaluated respiratory symptoms and measured airway obstruction to identify the impact of HAART and other risk factors on respiratory symptoms and pulmonary function.…”
Get full text
Article -
14
Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs.
Published 2010-06-01Get full text
Article -
15
Opportunistic Cryptococcal Antigenemia in the HAART Era at HIV Epidemic Settings of Northwest Ethiopia
Published 2020-01-01Get full text
Article -
16
Evaluation of Fundoscopic Findings in HIV Positive Patients in Relation to HAART and CD4 Count
Published 2018-10-01Subjects: Get full text
Article -
17
Nutritional status of HIV-positive individuals on free HAART treatment in a developing nation
Published 2010-08-01Subjects: Get full text
Article -
18
Level of Cardiovascular Disease Risk and Associated Factors among Clients on Highly Active Antiretroviral Therapy in Vihiga County, Kenya
Published 2024-09-01Subjects: “…Cardiovascular risk, HAART…”
Get full text
Article -
19
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.
Published 2006-11-01“…<h4>Background</h4>Adherence to highly active antiretroviral therapy (HAART) medication is the greatest patient-enabled predictor of treatment success and mortality for those who have access to drugs. …”
Get full text
Article -
20
Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: The role of fusion inhibitors in HAART
Published 2008-05-01Subjects: “…highly active antiretroviral therapy (haart)…”
Get full text
Article